Study how social rewards work in early schizophrenia
Part of Brain & nervous system, Mental health clinical trials.
This study looks at how your brain learns from positive social experiences in people who are in the early stages of schizophrenia-type illness. It may help researchers understand “social anhedonia” (feeling less pleasure or reward from social situations) and guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 35 years old
- Have a first episode of a psychotic illness that started within the last 3 years
- Have a diagnosis of schizophrenia, schizophreniform, or schizoaffective disorder
- Be taking a second-generation (newer) antipsychotic medicine
- Be able to do brain scanning (no pacemaker/unsafe metal) and be willing to scan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the brain and behavior relate to loneliness and feeling socially isolated in people with serious mental health conditions. It may help researchers understand what drives loneliness and how it could be addressed in the future.
This study tests whether a cognitive training program can help young adults with recent psychosis improve their thinking and memory skills. It involves brain scans and cognitive exercises.
This study uses a brain scan called magnetoencephalography (MEG) to understand brain activity in people with schizophrenia. It may help researchers learn more about the condition and could lead to better treatments.
This study looks at how people with early psychosis (within the first 5 years of treatment) talk during conversations. Researchers hope to learn more about speech patterns and brain activity related to psychosis.
This study tests whether using brain scans and genetic tests can help choose the best treatment for people early in their schizophrenia. It will check if these biomarkers can predict who will respond better to medication.
This study looks at how differences in brain activity and thinking patterns affect social outcomes in people with schizophrenia. It aims to develop better ways to measure and predict social functioning.
Hear when a new Psychosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.